Lauren P. Silvernail
Overview
Lauren P. Silvernail received an average of $1M in total compensation, including $361K in salary, at Revance Therapeutics from 2014 to 2018.
2018Revance TherapeuticsFormer Chief Financial Officer and Chief Business Officer
2017Revance TherapeuticsFormer Chief Financial Officer and Chief Business Officer
2016Revance TherapeuticsChief Financial Officer and Chief Business Officer
2015Revance TherapeuticsChief Financial Officer and Chief Business Officer
2014Revance TherapeuticsChief Financial Officer and Chief Business Officer
Source: SEC filings on March 25, 2019, March 24, 2017, and March 18, 2016.
Related executives
We found 12 more executives who work or worked at Revance Therapeutics.
Mark Foley
Revance Therapeutics
Chief Executive Officer
Dustin Sjuts
Revance Therapeutics
President
Aubrey Rankin
Revance Therapeutics
Former President, Innovation & Technology
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
Dwight Moxie
Revance Therapeutics
General Counsel
L Browne
Revance Therapeutics
Chief Executive Officer
Caryn McDowell
Revance Therapeutics